Thebaine-Derived Buprenorphine 8mg Sublingual Films from Japan
Sublingual films with 8mg buprenorphine, derived from thebaine alkaloid, for opioid use disorder treatment, in measured unit doses for retail. Fits HTS 3004.49.00 as alkaloid derivative transdermal-like system.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
Import Tips
• Comply with SAMHSA guidelines for opioid substitution therapies
• Validate film uniformity and dissolution for FDA approval